Can NMN Help with Age-Related Dry Mouth and Improve Longevity?

Author Profile Image

- Updated by Jody Mullis
Medically reviewed by Dr. Sidra Samad

  • Nicotinamide mononucleotide (NMN) significantly improves saliva production in aged mice.
  • Age-related dry mouth may be linked to lower levels of NAD+ in cells.
  • NMN treatment reduces cellular aging markers in the salivary glands.
  • It restores the expression of crucial water transport proteins in the glands.
  • This study highlights NMN’s potential for combating aging-related tissue dysfunction.
  • The results may inform treatments for age-related dry mouth in humans.

 

Why This Matters to Us:

As longevity enthusiasts, we are always looking for ways to mitigate the impact of aging on the body, particularly those that improve quality of life and overall health. Dry mouth is a common problem among older adults, leading to issues like difficulty swallowing, increased risk of oral infections, and even aspiration pneumonia. This study’s findings suggest that NMN, a precursor to NAD+ often discussed in longevity research, may provide a practical solution to one of aging’s smaller yet impactful challenges. If NMN can not only address dry mouth but also rejuvenate the tissues involved, it offers exciting potential as part of a broader anti-aging strategy.


The Detail:

Dry mouth occurs when the salivary glands produce less saliva, which happens naturally as we age, but it can also be a side effect of medications. With less saliva, the mouth becomes dry, uncomfortable, and prone to bacterial issues, which can lead to more serious health complications if untreated.

This study, conducted on mice, explored whether nicotinamide mononucleotide (NMN), a compound commonly used in studies on cellular aging, could restore salivation in old age. NMN is known to raise levels of NAD+ (nicotinamide adenine dinucleotide), a molecule essential for energy production and DNA repair in cells. As we age, NAD+ levels naturally decline, leading to less efficient functioning of many systems in the body.

The researchers focused on a specific salivary gland in the mouth called the submandibular gland, which is responsible for producing much of our saliva. Older mice in the study showed clear signs of reduced saliva production compared to younger mice. Salivation in these older mice was less than half that seen in younger ones. However, after four weeks of treatment with NMN, saliva secretion in older mice improved substantially, to levels nearly matching those of their younger counterparts.

One of the reasons the salivary glands function poorly with age is due to the accumulation of senescent cells. Senescent cells don’t die when they should; instead, they linger in tissues and release inflammatory signals that contribute to dysfunction. In this study, NMN treatment reduced markers associated with cellular senescence, such as a protein called SA-β-gal, in the submandibular glands of older mice. This reduction in senescent cells may explain part of why the glands began to function more effectively after NMN treatment. In simpler terms, the researchers observed that NMN is capable of cleaning up aged cells that interfere with normal tissue processes.

Another focus of the study was on aquaporin-5 (AQP5), a protein that helps move water molecules in and out of cells. This protein is crucial because salivary glands need it to maintain proper saliva flow. In older mice not treated with NMN, AQP5 activity was significantly reduced, contributing to lower saliva secretion. However, NMN restored the gene expression of AQP5 to levels similar to those found in younger mice, further improving gland functionality.

The researchers also measured levels of NAD+ in the tissues of the salivary glands. They found that NAD+ was naturally reduced in older mice but restored to higher levels following NMN treatment. This suggests that the loss of NAD+ may be a central factor in age-related decline of salivary glands, meaning that boosting NAD+ with NMN could reverse or slow down this decline.

Ultimately, this study highlights the importance of addressing the biological roots of dry mouth. By treating the underlying cellular changes, such as senescence and NAD+ depletion, instead of merely managing symptoms, NMN may offer a future solution for older adults experiencing this issue.


A Look Towards the Future:

It’s important to note that this research is still in its early stages and was conducted in mice. While the results are promising, human studies are needed to confirm whether NMN could be similarly effective in tackling dry mouth in older adults. If future trials are successful, NMN may become a simple, non-invasive treatment for improving salivation and preventing related oral health issues as people age.

For longevity enthusiasts, this study adds to the growing body of evidence supporting NMN’s role in slowing down or reversing age-related decline. Restoring NAD+ levels in tissues throughout the body could prove to be a powerful strategy for maintaining better health into old age—not just for salivary glands but for many other organ systems prone to dysfunction over time.

If NMN can help restore salivation and reduce the buildup of senescent cells, it not only improves the lives of older adults but also offers further proof of how targeting aging at a molecular level can be transformative.